Newsletter | August 27, 2026

08.27.26 -- New Insights For Safer, Smarter Medtech

SPONSOR

Successfully Navigating Opportunities With On-Body Delivery Systems – Common Questions And Answers

Container Closure Integrity (CCI) is essential to ensure sterile drug products remain safe, effective, and contamination-free throughout their shelf life. USP <1207> recommends evaluating package integrity from development through commercialization by defining the Maximum Allowable Leakage Limit (MALL) and selecting validated, application-specific test methods. The guidance favors quantitative deterministic methods over probabilistic approaches and emphasizes integrating CCI testing, seal quality assessment, stability studies, and lifecycle management to maintain product quality.

FEATURED EDITORIAL

A Much-Improved Approach For Understanding And Managing Safety Risks

Learn how causal mechanism and effect analysis (CMEA) and its principles can be used to develop and maintain safer working environments in the medical device industry.

INDUSTRY INSIGHTS

Cultural Audits: What Are They And Why Are They Essential?

The medical device industry is familiar with quality audits, but is less familiar with the benefits of having a cultural audit to assess the competence, dedication, and passion that each party brings to the table.

Embrace A Contract Manufacturer Partnership That Drives Sustainability

Medtech OEMs, contract manufacturers, and other partners involved in the device life cycle are increasingly realizing additional benefits by making sustainability a group exercise.

Fluoropolymer Tubing Guide

Explore how temperature thresholds, purity needs, and optical clarity requirements drive fluoropolymer tubing selection for clinical analyzers, immunoassay platforms, and flow cytometry applications.

RESOURCES

Mitigating Risk With The Right Contract Manufacturing Partner

Pharma+ Tubing Retainers

Modernizing Regulated Product Development And Manufacturing

Connect With Med Device Online: